AXA vs Mapfre (CS.PA vs MAP)

AXA (CS.PA) vs Mapfre (MAP) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

AXA (CS.PA) and Mapfre (MAP) compete in insurance. Here are AXA and Mapfre side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy AXA or Mapfre.

AXA vs Mapfre: the figures

AXA and Mapfre figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that AXA or Mapfre figure is not available, and we never estimate it.

3 key differences between AXA and Mapfre

1. Growth: Mapfre grew sales +43.1% year on year in its latest quarter, against +4.5% for AXA.
2. Size: AXA is worth €91.4 billion on the stock market, about 7.1 times Mapfre (€12.9 billion).
3. Profitability: for every 100 of sales, AXA keeps 10.4 as net profit and Mapfre keeps 3.9.

AXA or Mapfre: which fits your profile

• If you want growth: Mapfre is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): AXA pays the higher dividend relative to its price.
• If you prefer caution: Mapfre has a less volatile share price, which usually gives more room in a bad year.
• If price is what matters most to you: Mapfre trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither AXA nor Mapfre wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How AXA and Mapfre make money

AXA (CS.PA)

AXA collects insurance premiums in three lines: Property & Casualty (auto, home and commercial, including AXA XL for large corporate risks), its largest; Life & Savings; and Health. It operates mainly in France, the rest of Europe and Asia, and profits both from underwriting and from investing the premiums it holds. Full AXA analysis.

Mapfre (MAP)

Mapfre sells auto, home, life, health and commercial insurance, earning from premiums and from investing that money. It reports by region: Iberia, covering Spain and Portugal and its biggest market, Latin America, led by Brazil and Mexico, North America and Eurasia. Mapfre Re runs its reinsurance business. Full Mapfre analysis.

Frequently asked questions: AXA vs Mapfre

Is AXA or Mapfre the better stock?

Choosing between AXA and Mapfre depends on what you are looking for. Mapfre is growing faster right now, and Mapfre trades on the lower P/E. Fintols does not tell you whether to buy AXA or Mapfre: it shows you the differences so you can decide.

Which pays a higher dividend, AXA or Mapfre?

As of November 4, 2026, AXA yields 5.39% and Mapfre yields 4.48%. Also check how much of their profit AXA and Mapfre pay out: if it is more than they earn, it cannot last.

Which is more expensive, AXA or Mapfre?

On P/E, AXA (12.2x) is more expensive than Mapfre (11.0x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both AXA and Mapfre?

Yes. Many people spread their money across several companies, such as AXA and Mapfre, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying AXA or Mapfre.

More comparisons with AXA or Mapfre

• AXA vs Munich Re
• Allianz vs AXA
• Mapfre vs Munich Re
• Allianz vs Mapfre

More companies like AXA and Mapfre: insurance stocks. Educational content about AXA and Mapfre, not investment advice.